Brain Cancer Vaccine Doubles Survival Rates in Trial

A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, doubled survival rates in early trials and kept one patient cancer-free for nearly five years.

The vaccine trains each patient's immune system to recognize up to 40 unique cancer proteins, making it harder for tumors to hide.